Emergent signs $480M manufacturing deal with Johnson & Johnson for Covid-19 vaccine

The agreement comes just a couple of months after the Maryland biotech struck a $135 million deal with the New Jersey company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.